ISRG
INTUITIVE SURGICAL INC
Healthcare • Nasdaq • CIK 0001035267
Loading...
Market Cap
$143.91B
P/E (TTM)
46.0x
Rev Growth (TTM)
+20.7%
Net Margin (TTM)
28.4%
FCF Yield (TTM)
2.2%
FCF Margin (TTM)
29.2%
Figures as of June 30, 2026
Filings
Primary-source SEC disclosures, read end-to-end — every figure traceable to its filing.
8-KJul 20262026-07-27source
10-Q2026 Q22026-07-21source
8-KEarnings2026-07-16source
8-KMay 20262026-05-28source
8-KMay 20262026-05-04source
What your agent reads
Investor Relations
Company-published material — management’s own words, not SEC-audited. Each source below is labeled so your agent knows what to verify.
IR decks — not catalogued
Company-published, not SEC-audited
Earnings
Q2
3 months ago
8-K releaseRevenue
$2.89B
—
Net Income
$823.20M
—
EPS
$2.29
+26.5%
Most recent quarterly earnings snapshot
Cash Flow Health
Free Cash Flow8/8 positive
TTM$3.2B
Q2 '26
$948.4M+17%
Q1 '26
$808.6M+11%
FCF Margin
TTM29.2%
Q2 '2632.8%+12%
Sector: 0.7%Top 10%
OCF Margin
33.6%
OCF/NI1.18x
CapEx Coverage
7.7x
FCF Yield2.2%
FCF Growth (3Y)+40%
Cash Conversion Cycle
204 days
DSO: 48+DIO: 184−DPO: 29
Cash flow trends & capital efficiency
Capital Allocation
Total Shareholder YieldTTM
TTM2.5%
Dividend & Payout Metrics
Dividend Yield (TTM)—
Free Cash Flow (TTM)$3.2B
Stock Repurchases (TTM)$3.6B
Capital Return / FCF110.4%
Shares Outstanding (YoY)-1.3%↓ Buyback
Shows how management rewards shareholders
Valuation Metrics
Price-to-EarningsTTM
46.0x
Volatile
8Q: 63.3x-2900%
Valuation Lenses
Earnings
46.0x
vs – sector
Cash Flow
43.0x
EV/FCF vs –
Growth-Adj
2.1xPEG
Expensive for growth
Quality-Adj
2.8P/E per %ROIC
ROIC: 16.3%
Shareholder Returns
Dividend
–
Buyback
2.5%
Total Yield
2.5%
Market Cap$143.91B
EV$138.69B
Multi-angle valuation analysis with sector context
Margins & Efficiency
ROIC 75th pctile
Profitability Cascade
Gross
66.7%
Operating
31.3%
Top 25% in sector
Net
28.4%
Margins Unknown
Return on Invested CapitalTTM
16.3%
Stable
+0.0% YoY8Q: 15.1%+3.6%
P25MedianP75
75th pctl (med: -7.4%)
DuPont BreakdownROIC = Margin × Turn × (1+D/E)
NOPAT Margin
26.0%
8Q: 25.5%
Asset Turnover
0.55x
8Q: 0.52x
Leverage (1+D/E)
1.00x
D/E: 0.00x
DuPont: 14.2% ≈ 16.3% ROIC
Asset & CapEx Efficiency
Fixed Asset Turn
2.08x
8Q:2.02x
+15.2%
Invested Cap Turn
0.85x
8Q:0.83x
Flat
CapEx Intensity
3.7%
8Q:4.6%
CapEx/Depreciation
12.83x
FCF vs Net Margin Gap+0.8 pts
Margin trends, ROIC, and capital efficiency
Balance Sheet & Solvency
Net Cash
Net Debt / EBITDA
Net Cash
(0.8x)Net Cash: $5.22B
Interest Coverage
–
+Net cash position: $5.22B
Leverage Metrics
Debt-to-Equity
0.00x
Balance sheet risk & solvency analysis
Related Research
2 related posts